CS
VRXAW

Clear Street’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

Clear Street’s Portfolio VRXAW Stock Details VRXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.5K Buy
+485,358
New +$85.6K ﹤0.01% 956

Other funds holding VRXAW

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Clear Street's VRXAW Position: Q2 2026 in Review

Clear Street opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q2 2026: 485,358 shares worth $53.5K. The stake represents ﹤0.01% of the portfolio and ranks #956 among its holdings.

9 funds tracked by Wall St. Rank hold VRXAW as of Q2 2026.

  • Clear Street held 485,358 shares of Veraxa Biotech AG Warrants worth $53.5K as of Q2 2026.
  • Veraxa Biotech AG Warrants was a new Clear Street position in Q2 2026.
  • Veraxa Biotech AG Warrants made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #956 holding.
  • 9 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.